Special Issue "Innovative Approaches in Lung Cancer Treatment"
Deadline for manuscript submissions: closed (25 November 2023) | Viewed by 6685
Interests: minimally invasive thoracic surgery; robotic surgery; thoracic surgery; thoracic oncology; lung cancer; thoracic neoplasms
Background: In the last 15 years, we witnessed significant progress in the field of thoracic surgery and oncology.
Aim and scope: We aim to publish articles describing innovative approaches in the treatment of lung cancer, such as minimally invasive and robotic surgery, electromagnetic navigation bronchoscopy, 3D techniques or medical innovative treatments.
History: With the advent of new technologies, methods and treatments, we witnessed important improvements in immediate post-operative clinical conditions of the patients undergoing lung surgery and, more generally, improvements in the middle and long-term prognosis of these patients.
Cutting-edge research: The advantages of minimally invasive surgery, endobronchial diagnosis or target therapy and immunotherapy in the treatment of advanced lung cancer have been investigated for the management of lung cancer.
What kind of paper we are looking for: We encourage the submission of manuscripts that describe an innovative approach in the treatment of lung cancer, both surgical and medical.
Dr. Antonio Mazzella
Prof. Dr. Stéphane Renaud
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- lung cancer
- minimally invasive surgery
- robotic surgery
- innovative approaches
- navigation bronchoscopy
- innovative medical treatments
- future perspectives